1. Home
  2. DRTS vs PHR Comparison

DRTS vs PHR Comparison

Compare DRTS & PHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$7.52

Market Cap

641.6M

Sector

Health Care

ML Signal

HOLD

Logo Phreesia Inc.

PHR

Phreesia Inc.

HOLD

Current Price

$9.67

Market Cap

713.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRTS
PHR
Founded
2015
2005
Country
Israel
United States
Employees
121
N/A
Industry
Medical/Dental Instruments
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
641.6M
713.2M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
DRTS
PHR
Price
$7.52
$9.67
Analyst Decision
Strong Buy
Buy
Analyst Count
3
18
Target Price
$8.67
$21.18
AVG Volume (30 Days)
330.6K
1.6M
Earning Date
05-18-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
103.92
EPS
N/A
0.04
Revenue
N/A
$480,591,000.00
Revenue This Year
N/A
$8.43
Revenue Next Year
$699.98
$5.10
P/E Ratio
N/A
$241.25
Revenue Growth
N/A
14.48
52 Week Low
$2.59
$7.77
52 Week High
$8.80
$32.76

Technical Indicators

Market Signals
Indicator
DRTS
PHR
Relative Strength Index (RSI) 48.11 50.42
Support Level $6.47 $7.78
Resistance Level $7.75 $12.68
Average True Range (ATR) 0.56 0.45
MACD -0.02 0.17
Stochastic Oscillator 19.00 80.76

Price Performance

Historical Comparison
DRTS
PHR

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

About PHR Phreesia Inc.

Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.

Share on Social Networks: